AU2024903409A0 - Antigen-binding Molecules and Uses Thereof - Google Patents

Antigen-binding Molecules and Uses Thereof

Info

Publication number
AU2024903409A0
AU2024903409A0 AU2024903409A AU2024903409A AU2024903409A0 AU 2024903409 A0 AU2024903409 A0 AU 2024903409A0 AU 2024903409 A AU2024903409 A AU 2024903409A AU 2024903409 A AU2024903409 A AU 2024903409A AU 2024903409 A0 AU2024903409 A0 AU 2024903409A0
Authority
AU
Australia
Prior art keywords
antigen
binding molecules
molecules
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2024903409A
Inventor
Not Known
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adelaide University
Envision Sciences Pty Ltd
Original Assignee
University of South Australia
Envision Sciences Pty Ltd
Filing date
Publication date
Application filed by University of South Australia, Envision Sciences Pty Ltd filed Critical University of South Australia
Publication of AU2024903409A0 publication Critical patent/AU2024903409A0/en
Priority to PCT/AU2025/051194 priority Critical patent/WO2026085565A1/en
Abandoned legal-status Critical Current

Links

AU2024903409A 2024-10-22 2024-10-22 Antigen-binding Molecules and Uses Thereof Abandoned AU2024903409A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/AU2025/051194 WO2026085565A1 (en) 2024-10-22 2025-10-22 Antigen-binding molecules and uses thereof

Publications (1)

Publication Number Publication Date
AU2024903409A0 true AU2024903409A0 (en) 2024-10-31

Family

ID=

Similar Documents

Publication Publication Date Title
CA3261511A1 (en) Cd98hc antigen-binding domains and uses therefor
CA3261185A1 (en) Cnx antigen-binding molecules
CA3263086A1 (en) Bispecific anti-c-kit and anti-cd203c antigen-binding molecules and uses thereof
CA3261989A1 (en) Anti-steap1 antigen-binding molecules and uses thereof
AU2022340808B2 (en) Antigen-binding molecules and uses thereof
AU2024903409A0 (en) Antigen-binding Molecules and Uses Thereof
AU2024901760A0 (en) Antigen-binding molecules and uses thereof
AU2024207151A1 (en) Anti-tnfr2 antigen-binding proteins and uses thereof
AU2023903351A0 (en) Antigen-binding Molecules and Uses Thereof
AU2023903254A0 (en) Antigen-binding molecules and uses thereof
HK40112679A (en) Antigen-binding molecules and uses thereof
AU2025901307A0 (en) Molecules and Uses Therefor
AU2024902111A0 (en) Molecules and uses therefor
HK40101239A (en) Antigen-binding molecules and uses thereof
AU2020900632A0 (en) Antigen-binding molecules and uses thereof
AU2024308755A1 (en) Gpc3-targeted molecules and uses thereof
CA3296761A1 (en) Gpc3-targeted molecules and uses thereof
AU2023902144A0 (en) Molecules and uses therefor
HK40117765A (en) Humanized anti-tdp-43 binding molecules and uses thereof
CA3295242A1 (en) Cd40 x cd40 bispecific antigen-binding molecules and uses thereof
HK40120368A (en) Anti-idiotype antibody molecules and uses thereof
CA3291057A1 (en) Anti-trailr2 antigen-binding proteins and uses thereof
CA3275753A1 (en) Anti-tnfr2 antigen-binding proteins and uses thereof
HK40095919A (en) Humanized anti-tdp-43 binding molecules and uses thereof
CA3280676A1 (en) Anti-cd180 binding molecules and uses thereof